2 results
Approved WMOCompleted
The aim of this study is to investigate what proportion of HBeAg negative, inactive carriers of the hepatitis B virus with low (< 20,000 IU/mL) load will lose HBsAg when treated with nucleot(s)ide analogue/Peg-IFN combination therapy.
Approved WMORecruiting
To evaluate the efficacy and safety of the Focal C2 CryoBalloon* Ablation System (FCBAS) for the treatment of Barrett*s epithelium.